Brean Capital analyst Robert Farnam downgraded W. R. Berkley (WRB) to Neutral from Buy with a $73 price target upon resuming coverage. While calling W. R. Berkley “among the country’s largest and best-performing specialty commercial lines writers,” the firm expects top-line growth to slow over the next few years due to softening market conditions in several lines, the analyst tells investors.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WRB:
- W. R. Berkley downgraded to Neutral from Buy at Brean Capital
- W. R. Berkley price target lowered to $75 from $76 at Cantor Fitzgerald
- W. R. Berkley price target lowered to $71 from $75 at UBS
- W. R. Berkley price target lowered to $73 from $74 at Morgan Stanley
- W. R. Berkley Balances Record Earnings With Market Risks